These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 325019)

  • 1. Further studies on the reliability of the bacitracin inhibition test for the presumptive identification of Lancefield group A streptococci.
    Coleman DJ; McGhie D; Tebbutt GM
    J Clin Pathol; 1977 May; 30(5):421-6. PubMed ID: 325019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Should bacitracin sensitivity be used in the presumptive identification of group A streptococci?
    Menon T; Lloyd C; Jacob S
    Indian J Med Microbiol; 2005 Oct; 23(4):275. PubMed ID: 16327133
    [No Abstract]   [Full Text] [Related]  

  • 3. The bacitracin sensitivity test for identifying beta-haemolytic streptococci of Lancefield group A.
    Mondkar AD; Kelkar SS
    J Postgrad Med; 1981 Apr; 27(2):86-9. PubMed ID: 7024532
    [No Abstract]   [Full Text] [Related]  

  • 4. [Problems with identification of beta-hemolytic streptococcus resistant to bacitracin isolated from patients with pharyngitis].
    Olender A; Łetowska I; Karyński M; Kiernicka-Ciekot K; Pels K
    Med Dosw Mikrobiol; 2012; 64(1):1-10. PubMed ID: 22808724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bacitracin differentiation for presumptive identification of group A beta-hemolytic streptococci: comparison of primary and purified plate testing.
    Murray PR; Wold AD; Hall MM; Washington JA
    J Pediatr; 1976 Oct; 89(4):576-9. PubMed ID: 784929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Differentiation of serologic group A streptococci from group C and G using disks with various bacitracin levels].
    Urbásková P; Motlová J; Benes O; Jelínková J
    Cesk Epidemiol Mikrobiol Imunol; 1993 Jun; 42(2):76-7. PubMed ID: 8348626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid slide agglutination test for Lancefield grouping of streptococci.
    Damask LJ; Montoya O; Axelrod JL
    Arch Pathol Lab Med; 1979 Aug; 103(9):456-8. PubMed ID: 380509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid differentiation of Streptococcus milleri from other beta-haemolytic group A, C, and G streptococci by simple screening tests.
    O'Neill WA; Cooke RP
    Br J Biomed Sci; 1994 Mar; 51(1):1-4. PubMed ID: 7841829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical trial comparing bacitracin with Strep-A-Chek for accuracy and turnaround time in the presumptive identification of Streptococcus pyogenes.
    Yajko DM; Lawrence J; Nassos P; Young J; Hadley WK
    J Clin Microbiol; 1986 Sep; 24(3):431-4. PubMed ID: 3531230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presumptive identification of streptococci with a new test system.
    Facklam RR; Thacker LG; Fox B; Eriquez L
    J Clin Microbiol; 1982 Jun; 15(6):987-90. PubMed ID: 7050157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluation of bacitracin-sensitivity test for the screening of group A hemolytic streptococci].
    Kashiwagi Y; Shibata M; Tokue S; Tominaga Y; Okubo N
    Kansenshogaku Zasshi; 1975 Mar; 49(3):117-20. PubMed ID: 811718
    [No Abstract]   [Full Text] [Related]  

  • 12. Bacitracin and coagglutination for grouping of beta-hemolytic streptococci.
    Stoner RA
    J Clin Microbiol; 1978 May; 7(5):463-6. PubMed ID: 350895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the Strep-A-Chek technique for presumptive identification of group A beta-hemolytic streptococci and group D enterococci.
    Daly JA; Rufener ML
    Diagn Microbiol Infect Dis; 1987 Jul; 7(3):215-8. PubMed ID: 3308307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [To the problem of reliability of the bacitracin test in diagnostics of streptococcus pyogenes strains (author's transl)].
    Jelínková J; Motlová J
    Cesk Epidemiol Mikrobiol Imunol; 1973 Nov; 22(6):328-37. PubMed ID: 4271763
    [No Abstract]   [Full Text] [Related]  

  • 15. A new approach for presumptive identification of clinically important streptococci.
    Hussain Z; Lannigan R; Stoakes L
    Zentralbl Bakteriol Mikrobiol Hyg A; 1984 Oct; 258(1):74-9. PubMed ID: 6441390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dissemination of emm28 erythromycin-, clindamycin- and bacitracin-resistant Streptococcus pyogenes in Spain.
    Perez-Trallero E; Garcia C; Orden B; Marimon JM; Montes M
    Eur J Clin Microbiol Infect Dis; 2004 Feb; 23(2):123-6. PubMed ID: 14712367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of fluorescent antibody, bacitracin susceptibility, latex agglutination, coagglutination, and API 20S for identifying group A streptococci.
    Lesher RJ; Casiano-Colon AE
    Can J Microbiol; 1985 Apr; 31(4):335-8. PubMed ID: 3891053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A rapid staphylococcal coagglutination technic to differentiate group A from other streptococcal groups.
    Matthieu DE; Wasilauskas BL; Stallings RA
    Am J Clin Pathol; 1979 Sep; 72(3):463-7. PubMed ID: 382835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Grouping of beta-haemolytic streptococci by using coagglutination, precipitation or bacitracin sensitivity.
    Arvilommi H
    Acta Pathol Microbiol Scand B; 1976 Apr; 84(2):79-84. PubMed ID: 775887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of group A streptococci. Bacitracin disc and fluorescent antibody techniques compared with the Lancefield precipitin method.
    STREAMER CW; WILLIAMS PM; WANG WL; JOHNSON RS; McGUIRE CD; ABELOW IJ; GLASER RJ
    Am J Dis Child; 1962 Aug; 104():157-60. PubMed ID: 13917720
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.